avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Snai1
|
ENSMUSG00000042821.7 | snail family zinc finger 1 |
Zeb1
|
ENSMUSG00000024238.7 | zinc finger E-box binding homeobox 1 |
Snai2
|
ENSMUSG00000022676.6 | snail family zinc finger 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Snai1 | mm10_v2_chr2_+_167538192_167538210 | 0.48 | 2.9e-03 | Click! |
Snai2 | mm10_v2_chr16_+_14705832_14705858 | -0.37 | 2.8e-02 | Click! |
Zeb1 | mm10_v2_chr18_+_5591860_5591902 | -0.11 | 5.4e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr4_-_137430517 | 18.82 |
ENSMUST00000102522.4
|
Cela3b
|
chymotrypsin-like elastase family, member 3B |
chr4_-_137409777 | 12.50 |
ENSMUST00000024200.6
|
Gm13011
|
predicted gene 13011 |
chr2_-_28563362 | 11.34 |
ENSMUST00000028161.5
|
Cel
|
carboxyl ester lipase |
chr19_+_52264323 | 10.26 |
ENSMUST00000039652.4
|
Ins1
|
insulin I |
chr6_+_114131229 | 9.35 |
ENSMUST00000032451.7
|
Slc6a11
|
solute carrier family 6 (neurotransmitter transporter, GABA), member 11 |
chr8_-_105933832 | 8.63 |
ENSMUST00000034368.6
|
Ctrl
|
chymotrypsin-like |
chr6_+_41458923 | 8.47 |
ENSMUST00000031910.7
|
Prss1
|
protease, serine, 1 (trypsin 1) |
chr7_-_142578093 | 7.64 |
ENSMUST00000149974.1
ENSMUST00000152754.1 |
H19
|
H19 fetal liver mRNA |
chr8_-_122460666 | 7.61 |
ENSMUST00000006762.5
|
Snai3
|
snail homolog 3 (Drosophila) |
chr7_-_142578139 | 7.26 |
ENSMUST00000136359.1
|
H19
|
H19 fetal liver mRNA |
chr6_+_41392356 | 7.00 |
ENSMUST00000049079.7
|
Gm5771
|
predicted gene 5771 |
chr16_-_23890805 | 6.86 |
ENSMUST00000004480.3
|
Sst
|
somatostatin |
chr6_-_41035501 | 6.78 |
ENSMUST00000031931.5
|
2210010C04Rik
|
RIKEN cDNA 2210010C04 gene |
chr3_-_20275659 | 6.66 |
ENSMUST00000011607.5
|
Cpb1
|
carboxypeptidase B1 (tissue) |
chr11_+_69965396 | 6.52 |
ENSMUST00000018713.6
|
Cldn7
|
claudin 7 |
chr7_-_142679533 | 6.35 |
ENSMUST00000162317.1
ENSMUST00000125933.1 ENSMUST00000105931.1 ENSMUST00000105930.1 ENSMUST00000105933.1 ENSMUST00000105932.1 ENSMUST00000000220.2 |
Ins2
|
insulin II |
chr6_+_30639218 | 5.87 |
ENSMUST00000031806.9
|
Cpa1
|
carboxypeptidase A1, pancreatic |
chr10_+_75564086 | 5.57 |
ENSMUST00000141062.1
ENSMUST00000152657.1 |
Ggt1
|
gamma-glutamyltransferase 1 |
chr4_-_116167591 | 5.53 |
ENSMUST00000030465.3
ENSMUST00000143426.1 |
Tspan1
|
tetraspanin 1 |
chr6_+_78425973 | 5.31 |
ENSMUST00000079926.5
|
Reg1
|
regenerating islet-derived 1 |
chr6_+_41354105 | 5.25 |
ENSMUST00000072103.5
|
Try10
|
trypsin 10 |
chr1_+_72824482 | 5.21 |
ENSMUST00000047328.4
|
Igfbp2
|
insulin-like growth factor binding protein 2 |
chr9_-_21312255 | 4.87 |
ENSMUST00000115433.3
ENSMUST00000003397.7 |
Ap1m2
|
adaptor protein complex AP-1, mu 2 subunit |
chr7_-_142657466 | 4.85 |
ENSMUST00000097936.2
ENSMUST00000000033.5 |
Igf2
|
insulin-like growth factor 2 |
chr8_-_111691002 | 4.81 |
ENSMUST00000034435.5
|
Ctrb1
|
chymotrypsinogen B1 |
chr17_-_26201363 | 4.67 |
ENSMUST00000121959.1
|
Arhgdig
|
Rho GDP dissociation inhibitor (GDI) gamma |
chr15_+_85017138 | 4.52 |
ENSMUST00000023070.5
|
Upk3a
|
uroplakin 3A |
chr7_+_18884679 | 4.40 |
ENSMUST00000032573.6
|
Pglyrp1
|
peptidoglycan recognition protein 1 |
chr6_+_41521782 | 4.33 |
ENSMUST00000070380.4
|
Prss2
|
protease, serine, 2 |
chr6_-_41446062 | 4.32 |
ENSMUST00000095999.5
|
Gm10334
|
predicted gene 10334 |
chr17_-_26201328 | 4.17 |
ENSMUST00000025019.2
|
Arhgdig
|
Rho GDP dissociation inhibitor (GDI) gamma |
chr12_+_110279228 | 4.17 |
ENSMUST00000097228.4
|
Dio3
|
deiodinase, iodothyronine type III |
chr6_-_41314700 | 4.16 |
ENSMUST00000064324.5
|
Try5
|
trypsin 5 |
chr1_+_93006328 | 4.16 |
ENSMUST00000059676.4
|
Aqp12
|
aquaporin 12 |
chr3_-_108536466 | 4.15 |
ENSMUST00000048012.6
ENSMUST00000106626.2 ENSMUST00000106625.3 |
5330417C22Rik
|
RIKEN cDNA 5330417C22 gene |
chr4_+_49059256 | 4.10 |
ENSMUST00000076670.2
|
E130309F12Rik
|
RIKEN cDNA E130309F12 gene |
chr4_+_155469114 | 4.04 |
ENSMUST00000178188.1
ENSMUST00000178238.1 ENSMUST00000023920.2 |
Tmem52
|
transmembrane protein 52 |
chr2_+_122637844 | 3.96 |
ENSMUST00000047498.8
|
AA467197
|
expressed sequence AA467197 |
chr14_+_103650208 | 3.96 |
ENSMUST00000069443.7
|
Slain1
|
SLAIN motif family, member 1 |
chr4_+_133480126 | 3.89 |
ENSMUST00000051676.6
|
Fam46b
|
family with sequence similarity 46, member B |
chr14_-_56102458 | 3.81 |
ENSMUST00000015583.1
|
Ctsg
|
cathepsin G |
chr12_-_4592927 | 3.64 |
ENSMUST00000170816.1
|
Gm3625
|
predicted gene 3625 |
chr1_-_134234492 | 3.63 |
ENSMUST00000169927.1
|
Adora1
|
adenosine A1 receptor |
chr15_+_89322969 | 3.59 |
ENSMUST00000066991.5
|
Adm2
|
adrenomedullin 2 |
chr2_+_122637867 | 3.51 |
ENSMUST00000110512.3
|
AA467197
|
expressed sequence AA467197 |
chr3_-_107221722 | 3.41 |
ENSMUST00000029504.8
|
Cym
|
chymosin |
chr9_+_46269069 | 3.41 |
ENSMUST00000034584.3
|
Apoa5
|
apolipoprotein A-V |
chrX_-_52613936 | 3.37 |
ENSMUST00000114857.1
|
Gpc3
|
glypican 3 |
chr10_-_128401218 | 3.36 |
ENSMUST00000042666.5
|
Slc39a5
|
solute carrier family 39 (metal ion transporter), member 5 |
chr4_-_141416002 | 3.34 |
ENSMUST00000006378.2
ENSMUST00000105788.1 |
Clcnkb
|
chloride channel Kb |
chr3_-_92485886 | 3.31 |
ENSMUST00000054599.7
|
Sprr1a
|
small proline-rich protein 1A |
chrX_-_52613913 | 3.30 |
ENSMUST00000069360.7
|
Gpc3
|
glypican 3 |
chr3_+_89229046 | 3.27 |
ENSMUST00000041142.3
|
Muc1
|
mucin 1, transmembrane |
chr6_+_41302265 | 3.22 |
ENSMUST00000031913.4
|
Try4
|
trypsin 4 |
chr8_+_71597648 | 3.18 |
ENSMUST00000143662.1
|
Fam129c
|
family with sequence similarity 129, member C |
chr5_-_100159261 | 3.15 |
ENSMUST00000139520.1
|
Tmem150c
|
transmembrane protein 150C |
chr1_+_74791516 | 3.14 |
ENSMUST00000006718.8
|
Wnt10a
|
wingless related MMTV integration site 10a |
chr2_-_62483637 | 3.13 |
ENSMUST00000136686.1
ENSMUST00000102733.3 |
Gcg
|
glucagon |
chr14_-_20269162 | 3.06 |
ENSMUST00000024155.7
|
Kcnk16
|
potassium channel, subfamily K, member 16 |
chr2_-_30474199 | 3.06 |
ENSMUST00000065134.2
|
Ier5l
|
immediate early response 5-like |
chr16_+_36693972 | 3.04 |
ENSMUST00000023617.6
ENSMUST00000089618.3 |
Ildr1
|
immunoglobulin-like domain containing receptor 1 |
chr6_-_88874597 | 3.04 |
ENSMUST00000061262.4
ENSMUST00000140455.1 ENSMUST00000145780.1 |
Podxl2
|
podocalyxin-like 2 |
chr12_-_76709997 | 3.04 |
ENSMUST00000166101.1
|
Sptb
|
spectrin beta, erythrocytic |
chrX_-_162964557 | 3.04 |
ENSMUST00000038769.2
|
S100g
|
S100 calcium binding protein G |
chr3_-_113532288 | 3.02 |
ENSMUST00000132353.1
|
Amy2a1
|
amylase 2a1 |
chr5_-_122049822 | 2.99 |
ENSMUST00000111752.3
|
Cux2
|
cut-like homeobox 2 |
chr10_+_75573448 | 2.99 |
ENSMUST00000006508.3
|
Ggt1
|
gamma-glutamyltransferase 1 |
chr2_+_164940742 | 2.97 |
ENSMUST00000137626.1
|
Mmp9
|
matrix metallopeptidase 9 |
chr17_-_31144271 | 2.96 |
ENSMUST00000024826.7
|
Tff2
|
trefoil factor 2 (spasmolytic protein 1) |
chr11_+_68556186 | 2.96 |
ENSMUST00000053211.6
|
Mfsd6l
|
major facilitator superfamily domain containing 6-like |
chr7_-_126704179 | 2.96 |
ENSMUST00000106364.1
|
Coro1a
|
coronin, actin binding protein 1A |
chr10_+_75568648 | 2.94 |
ENSMUST00000134503.1
ENSMUST00000125770.1 ENSMUST00000128886.1 ENSMUST00000151212.1 |
Ggt1
|
gamma-glutamyltransferase 1 |
chr5_-_124862368 | 2.94 |
ENSMUST00000036206.7
|
Ccdc92
|
coiled-coil domain containing 92 |
chr3_-_113324052 | 2.93 |
ENSMUST00000179314.1
|
Amy2a3
|
amylase 2a3 |
chr3_-_113291449 | 2.92 |
ENSMUST00000179568.1
|
Amy2a4
|
amylase 2a4 |
chr16_+_36694024 | 2.91 |
ENSMUST00000119464.1
|
Ildr1
|
immunoglobulin-like domain containing receptor 1 |
chr3_-_113258837 | 2.89 |
ENSMUST00000098673.3
|
Amy2a5
|
amylase 2a5 |
chr11_+_103171081 | 2.89 |
ENSMUST00000042286.5
|
Fmnl1
|
formin-like 1 |
chr10_-_128400448 | 2.88 |
ENSMUST00000167859.1
|
Slc39a5
|
solute carrier family 39 (metal ion transporter), member 5 |
chr2_+_119237351 | 2.87 |
ENSMUST00000028783.7
|
Spint1
|
serine protease inhibitor, Kunitz type 1 |
chr7_+_45617575 | 2.85 |
ENSMUST00000008605.5
|
Fut1
|
fucosyltransferase 1 |
chr16_-_18621366 | 2.84 |
ENSMUST00000051160.2
|
Gp1bb
|
glycoprotein Ib, beta polypeptide |
chr6_+_40964760 | 2.82 |
ENSMUST00000076638.5
|
1810009J06Rik
|
RIKEN cDNA 1810009J06 gene |
chr12_+_82616885 | 2.81 |
ENSMUST00000161801.1
|
Rgs6
|
regulator of G-protein signaling 6 |
chr15_-_97908261 | 2.79 |
ENSMUST00000023119.8
|
Vdr
|
vitamin D receptor |
chr15_-_85581809 | 2.78 |
ENSMUST00000023015.7
|
Wnt7b
|
wingless-related MMTV integration site 7B |
chr5_+_115466234 | 2.78 |
ENSMUST00000145785.1
ENSMUST00000031495.4 ENSMUST00000112071.1 ENSMUST00000125568.1 |
Pla2g1b
|
phospholipase A2, group IB, pancreas |
chr11_+_69964758 | 2.77 |
ENSMUST00000108597.1
ENSMUST00000060651.5 ENSMUST00000108596.1 |
Cldn7
|
claudin 7 |
chr9_+_110419750 | 2.77 |
ENSMUST00000035061.6
|
Ngp
|
neutrophilic granule protein |
chr6_-_78378851 | 2.74 |
ENSMUST00000089667.1
ENSMUST00000167492.1 |
Reg3d
|
regenerating islet-derived 3 delta |
chr17_-_56117265 | 2.72 |
ENSMUST00000113072.2
|
Plin5
|
perilipin 5 |
chr2_+_119237453 | 2.72 |
ENSMUST00000110816.1
|
Spint1
|
serine protease inhibitor, Kunitz type 1 |
chr9_+_111019284 | 2.71 |
ENSMUST00000035077.3
|
Ltf
|
lactotransferrin |
chr8_-_70439557 | 2.66 |
ENSMUST00000076615.5
|
Crtc1
|
CREB regulated transcription coactivator 1 |
chr6_-_40999479 | 2.64 |
ENSMUST00000166306.1
|
Gm2663
|
predicted gene 2663 |
chr12_+_109459843 | 2.63 |
ENSMUST00000173812.1
|
Dlk1
|
delta-like 1 homolog (Drosophila) |
chr4_-_141825997 | 2.63 |
ENSMUST00000102481.3
|
Cela2a
|
chymotrypsin-like elastase family, member 2A |
chr17_-_56117577 | 2.62 |
ENSMUST00000019808.5
|
Plin5
|
perilipin 5 |
chr11_+_87793470 | 2.59 |
ENSMUST00000020779.4
|
Mpo
|
myeloperoxidase |
chr6_+_29398920 | 2.58 |
ENSMUST00000181464.1
ENSMUST00000180829.1 |
Ccdc136
|
coiled-coil domain containing 136 |
chr18_-_35649349 | 2.58 |
ENSMUST00000025211.4
|
Mzb1
|
marginal zone B and B1 cell-specific protein 1 |
chr17_+_23679363 | 2.57 |
ENSMUST00000024699.2
|
Cldn6
|
claudin 6 |
chr2_-_114013619 | 2.57 |
ENSMUST00000090275.4
|
Gjd2
|
gap junction protein, delta 2 |
chr18_+_34840575 | 2.55 |
ENSMUST00000043484.7
|
Reep2
|
receptor accessory protein 2 |
chr19_-_11266122 | 2.52 |
ENSMUST00000169159.1
|
Ms4a1
|
membrane-spanning 4-domains, subfamily A, member 1 |
chr10_+_75568630 | 2.51 |
ENSMUST00000145928.1
|
Ggt1
|
gamma-glutamyltransferase 1 |
chr5_+_135980099 | 2.50 |
ENSMUST00000005073.6
|
Zp3
|
zona pellucida glycoprotein 3 |
chr6_-_69631933 | 2.49 |
ENSMUST00000177697.1
|
Igkv4-54
|
immunoglobulin kappa chain variable 4-54 |
chr1_-_75133866 | 2.49 |
ENSMUST00000027405.4
|
Slc23a3
|
solute carrier family 23 (nucleobase transporters), member 3 |
chr4_-_11386757 | 2.48 |
ENSMUST00000108313.1
ENSMUST00000108311.2 |
Esrp1
|
epithelial splicing regulatory protein 1 |
chr4_+_137707458 | 2.48 |
ENSMUST00000097837.4
|
Rap1gap
|
Rap1 GTPase-activating protein |
chr11_-_46312220 | 2.48 |
ENSMUST00000129474.1
ENSMUST00000093166.4 ENSMUST00000165599.2 |
Cyfip2
|
cytoplasmic FMR1 interacting protein 2 |
chr6_-_41377604 | 2.48 |
ENSMUST00000096003.5
|
Prss3
|
protease, serine, 3 |
chr8_-_64693027 | 2.47 |
ENSMUST00000048967.7
|
Cpe
|
carboxypeptidase E |
chr9_-_121792478 | 2.46 |
ENSMUST00000035110.4
|
Hhatl
|
hedgehog acyltransferase-like |
chr11_-_5152218 | 2.44 |
ENSMUST00000163299.1
ENSMUST00000062821.6 |
Emid1
|
EMI domain containing 1 |
chr9_-_75683992 | 2.43 |
ENSMUST00000034699.6
|
Scg3
|
secretogranin III |
chr8_-_46211284 | 2.43 |
ENSMUST00000034049.4
|
Slc25a4
|
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 4 |
chr12_-_112929415 | 2.41 |
ENSMUST00000075827.3
|
Jag2
|
jagged 2 |
chr7_+_45639964 | 2.41 |
ENSMUST00000148532.1
|
Mamstr
|
MEF2 activating motif and SAP domain containing transcriptional regulator |
chr8_+_84148025 | 2.40 |
ENSMUST00000143833.1
ENSMUST00000118856.1 |
4930432K21Rik
|
RIKEN cDNA 4930432K21 gene |
chr17_-_23684019 | 2.40 |
ENSMUST00000085989.5
|
Cldn9
|
claudin 9 |
chr2_-_163918683 | 2.39 |
ENSMUST00000044734.2
|
Rims4
|
regulating synaptic membrane exocytosis 4 |
chr2_-_28084877 | 2.39 |
ENSMUST00000028179.8
ENSMUST00000117486.1 ENSMUST00000135472.1 |
Fcnb
|
ficolin B |
chr2_-_54085542 | 2.38 |
ENSMUST00000100089.2
|
Rprm
|
reprimo, TP53 dependent G2 arrest mediator candidate |
chrX_-_143827391 | 2.38 |
ENSMUST00000087316.5
|
Capn6
|
calpain 6 |
chr10_+_24223517 | 2.37 |
ENSMUST00000095784.2
|
Moxd1
|
monooxygenase, DBH-like 1 |
chr9_-_42124276 | 2.37 |
ENSMUST00000060989.8
|
Sorl1
|
sortilin-related receptor, LDLR class A repeats-containing |
chr11_-_102365111 | 2.37 |
ENSMUST00000006749.9
|
Slc4a1
|
solute carrier family 4 (anion exchanger), member 1 |
chr10_+_128909866 | 2.36 |
ENSMUST00000026407.7
|
Cd63
|
CD63 antigen |
chr8_+_70373541 | 2.35 |
ENSMUST00000003659.7
|
Comp
|
cartilage oligomeric matrix protein |
chr7_+_26173411 | 2.35 |
ENSMUST00000082214.4
|
Cyp2b9
|
cytochrome P450, family 2, subfamily b, polypeptide 9 |
chr9_+_98490522 | 2.34 |
ENSMUST00000035029.2
|
Rbp2
|
retinol binding protein 2, cellular |
chr15_+_98634743 | 2.34 |
ENSMUST00000003442.7
|
Cacnb3
|
calcium channel, voltage-dependent, beta 3 subunit |
chr11_-_120648104 | 2.32 |
ENSMUST00000026134.2
|
Myadml2
|
myeloid-associated differentiation marker-like 2 |
chr16_+_87553313 | 2.31 |
ENSMUST00000026700.7
|
Map3k7cl
|
Map3k7 C-terminal like |
chr10_+_75948292 | 2.30 |
ENSMUST00000000926.2
|
Vpreb3
|
pre-B lymphocyte gene 3 |
chr7_+_26808880 | 2.29 |
ENSMUST00000040944.7
|
Cyp2g1
|
cytochrome P450, family 2, subfamily g, polypeptide 1 |
chr10_+_75568641 | 2.28 |
ENSMUST00000131565.1
|
Ggt1
|
gamma-glutamyltransferase 1 |
chr2_+_25395866 | 2.27 |
ENSMUST00000028328.2
|
Entpd2
|
ectonucleoside triphosphate diphosphohydrolase 2 |
chr2_+_119237531 | 2.27 |
ENSMUST00000110817.2
|
Spint1
|
serine protease inhibitor, Kunitz type 1 |
chr11_-_34208085 | 2.26 |
ENSMUST00000060271.2
|
Foxi1
|
forkhead box I1 |
chr10_+_79821006 | 2.23 |
ENSMUST00000169041.1
|
Misp
|
mitotic spindle positioning |
chr1_-_171196229 | 2.23 |
ENSMUST00000111332.1
|
Pcp4l1
|
Purkinje cell protein 4-like 1 |
chr11_-_120551126 | 2.22 |
ENSMUST00000026121.2
|
Ppp1r27
|
protein phosphatase 1, regulatory subunit 27 |
chr11_-_94242701 | 2.20 |
ENSMUST00000061469.3
|
Wfikkn2
|
WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 |
chr6_-_88875035 | 2.20 |
ENSMUST00000145944.1
|
Podxl2
|
podocalyxin-like 2 |
chrX_-_73660047 | 2.19 |
ENSMUST00000114472.1
|
Pnck
|
pregnancy upregulated non-ubiquitously expressed CaM kinase |
chr7_+_121734477 | 2.19 |
ENSMUST00000000221.5
|
Scnn1g
|
sodium channel, nonvoltage-gated 1 gamma |
chr2_+_92915080 | 2.19 |
ENSMUST00000028648.2
|
Syt13
|
synaptotagmin XIII |
chr13_-_62888282 | 2.19 |
ENSMUST00000092888.4
|
Fbp1
|
fructose bisphosphatase 1 |
chr18_+_36528145 | 2.17 |
ENSMUST00000074298.6
ENSMUST00000115694.2 |
Slc4a9
|
solute carrier family 4, sodium bicarbonate cotransporter, member 9 |
chr11_-_103749815 | 2.17 |
ENSMUST00000018630.2
|
Wnt9b
|
wingless-type MMTV integration site 9B |
chr8_+_105518736 | 2.17 |
ENSMUST00000034363.5
|
Hsd11b2
|
hydroxysteroid 11-beta dehydrogenase 2 |
chr11_+_7063423 | 2.16 |
ENSMUST00000020706.4
|
Adcy1
|
adenylate cyclase 1 |
chr8_-_109962127 | 2.13 |
ENSMUST00000001722.7
ENSMUST00000051430.6 |
Marveld3
|
MARVEL (membrane-associating) domain containing 3 |
chr4_-_11386679 | 2.12 |
ENSMUST00000043781.7
ENSMUST00000108310.1 |
Esrp1
|
epithelial splicing regulatory protein 1 |
chr14_-_56234650 | 2.11 |
ENSMUST00000015585.2
|
Gzmc
|
granzyme C |
chr7_+_141061274 | 2.10 |
ENSMUST00000048002.5
|
B4galnt4
|
beta-1,4-N-acetyl-galactosaminyl transferase 4 |
chr11_+_3983704 | 2.10 |
ENSMUST00000063004.7
|
Gal3st1
|
galactose-3-O-sulfotransferase 1 |
chr8_-_107065632 | 2.09 |
ENSMUST00000034393.5
|
Tmed6
|
transmembrane emp24 protein transport domain containing 6 |
chr10_+_95417352 | 2.08 |
ENSMUST00000181781.1
|
5730420D15Rik
|
RIKEN cDNA 5730420D15 gene |
chr7_-_31076656 | 2.08 |
ENSMUST00000167369.1
|
Fxyd3
|
FXYD domain-containing ion transport regulator 3 |
chr19_+_38132767 | 2.07 |
ENSMUST00000025956.5
ENSMUST00000112329.1 |
Pde6c
|
phosphodiesterase 6C, cGMP specific, cone, alpha prime |
chr11_-_101785252 | 2.07 |
ENSMUST00000164750.1
ENSMUST00000107176.1 ENSMUST00000017868.6 |
Etv4
|
ets variant gene 4 (E1A enhancer binding protein, E1AF) |
chr3_-_88548249 | 2.06 |
ENSMUST00000131775.1
ENSMUST00000008745.6 |
Rab25
|
RAB25, member RAS oncogene family |
chr16_+_20696175 | 2.06 |
ENSMUST00000128273.1
|
Fam131a
|
family with sequence similarity 131, member A |
chr10_+_79822617 | 2.04 |
ENSMUST00000046833.4
|
Misp
|
mitotic spindle positioning |
chr6_+_34412334 | 2.04 |
ENSMUST00000007449.8
|
Akr1b7
|
aldo-keto reductase family 1, member B7 |
chr3_-_100489324 | 2.04 |
ENSMUST00000061455.8
|
Fam46c
|
family with sequence similarity 46, member C |
chr7_+_13733502 | 2.04 |
ENSMUST00000086148.6
|
Sult2a2
|
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 2 |
chr16_-_16863975 | 2.03 |
ENSMUST00000100136.3
|
Igll1
|
immunoglobulin lambda-like polypeptide 1 |
chr11_-_69617879 | 2.01 |
ENSMUST00000005334.2
|
Shbg
|
sex hormone binding globulin |
chr11_+_3332426 | 2.01 |
ENSMUST00000136474.1
|
Pik3ip1
|
phosphoinositide-3-kinase interacting protein 1 |
chr1_+_74409376 | 1.99 |
ENSMUST00000027366.6
|
Vil1
|
villin 1 |
chr8_+_119700009 | 1.99 |
ENSMUST00000095171.3
|
Atp2c2
|
ATPase, Ca++ transporting, type 2C, member 2 |
chr3_-_132950043 | 1.98 |
ENSMUST00000117164.1
ENSMUST00000093971.4 ENSMUST00000042729.9 ENSMUST00000042744.9 ENSMUST00000117811.1 |
Npnt
|
nephronectin |
chr11_+_96929367 | 1.95 |
ENSMUST00000062172.5
|
Prr15l
|
proline rich 15-like |
chr11_+_3290300 | 1.94 |
ENSMUST00000057089.6
ENSMUST00000093402.5 |
Patz1
|
POZ (BTB) and AT hook containing zinc finger 1 |
chr16_-_16863817 | 1.94 |
ENSMUST00000124890.1
|
Igll1
|
immunoglobulin lambda-like polypeptide 1 |
chr4_+_133553370 | 1.93 |
ENSMUST00000042706.2
|
Nr0b2
|
nuclear receptor subfamily 0, group B, member 2 |
chr3_-_152166230 | 1.93 |
ENSMUST00000046614.9
|
Gipc2
|
GIPC PDZ domain containing family, member 2 |
chr4_+_106622424 | 1.92 |
ENSMUST00000047922.2
|
Ttc22
|
tetratricopeptide repeat domain 22 |
chrX_-_7671341 | 1.92 |
ENSMUST00000033486.5
|
Plp2
|
proteolipid protein 2 |
chr5_-_122050102 | 1.91 |
ENSMUST00000154139.1
|
Cux2
|
cut-like homeobox 2 |
chr2_-_164404606 | 1.91 |
ENSMUST00000109359.1
ENSMUST00000109358.1 ENSMUST00000103103.3 |
Matn4
|
matrilin 4 |
chr7_-_17056669 | 1.90 |
ENSMUST00000037762.4
|
Hif3a
|
hypoxia inducible factor 3, alpha subunit |
chr17_+_29093763 | 1.89 |
ENSMUST00000023829.6
|
Cdkn1a
|
cyclin-dependent kinase inhibitor 1A (P21) |
chr7_+_126272589 | 1.89 |
ENSMUST00000056028.9
|
Sbk1
|
SH3-binding kinase 1 |
chr7_+_13623967 | 1.87 |
ENSMUST00000108525.2
|
Sult2a5
|
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 5 |
chr11_+_115462464 | 1.87 |
ENSMUST00000106532.3
ENSMUST00000092445.5 ENSMUST00000153466.1 |
Slc16a5
|
solute carrier family 16 (monocarboxylic acid transporters), member 5 |
chr5_+_91517615 | 1.86 |
ENSMUST00000040576.9
|
Parm1
|
prostate androgen-regulated mucin-like protein 1 |
chr17_-_7385305 | 1.86 |
ENSMUST00000070059.3
|
Gm9992
|
predicted gene 9992 |
chr7_-_126704522 | 1.85 |
ENSMUST00000135087.1
|
Coro1a
|
coronin, actin binding protein 1A |
chr11_-_62648458 | 1.85 |
ENSMUST00000057194.8
|
Fam211a
|
family with sequence similarity 211, member A |
chr8_-_4259257 | 1.85 |
ENSMUST00000053252.7
|
Ctxn1
|
cortexin 1 |
chr5_-_108795352 | 1.84 |
ENSMUST00000004943.1
|
Tmed11
|
transmembrane emp24 protein transport domain containing |
chr14_-_70176787 | 1.83 |
ENSMUST00000153735.1
|
Pdlim2
|
PDZ and LIM domain 2 |
chr11_+_115974930 | 1.80 |
ENSMUST00000106460.2
|
Itgb4
|
integrin beta 4 |
chr11_+_3983636 | 1.79 |
ENSMUST00000078757.1
|
Gal3st1
|
galactose-3-O-sulfotransferase 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 6.2 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
2.0 | 16.3 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
2.0 | 6.0 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
1.7 | 5.0 | GO:0051714 | regulation of cytolysis in other organism(GO:0051710) positive regulation of cytolysis in other organism(GO:0051714) |
1.7 | 5.0 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) regulation of nucleoside transport(GO:0032242) |
1.6 | 8.0 | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
1.4 | 10.0 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
1.3 | 1.3 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
1.3 | 16.4 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
1.2 | 4.9 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
1.1 | 3.2 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
1.1 | 5.3 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
1.1 | 3.2 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
1.1 | 4.2 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
1.0 | 3.0 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
1.0 | 1.0 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.9 | 2.8 | GO:2000388 | positive regulation of ovarian follicle development(GO:2000386) regulation of antral ovarian follicle growth(GO:2000387) positive regulation of antral ovarian follicle growth(GO:2000388) |
0.9 | 3.7 | GO:1902896 | terminal web assembly(GO:1902896) |
0.9 | 2.7 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.9 | 2.6 | GO:0002149 | hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
0.8 | 2.5 | GO:0015866 | ADP transport(GO:0015866) |
0.8 | 2.5 | GO:0002215 | defense response to nematode(GO:0002215) |
0.8 | 2.4 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.8 | 2.4 | GO:0006589 | octopamine biosynthetic process(GO:0006589) octopamine metabolic process(GO:0046333) |
0.8 | 3.2 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.8 | 3.2 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
0.8 | 2.3 | GO:1990523 | bone regeneration(GO:1990523) |
0.8 | 2.3 | GO:0014064 | positive regulation of serotonin secretion(GO:0014064) |
0.8 | 3.0 | GO:0090345 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
0.8 | 5.3 | GO:0015840 | urea transport(GO:0015840) |
0.7 | 1.5 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.7 | 2.9 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.7 | 10.2 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.7 | 2.9 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
0.7 | 2.9 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.7 | 2.1 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
0.7 | 2.8 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.7 | 6.2 | GO:0070944 | neutrophil mediated killing of bacterium(GO:0070944) |
0.7 | 2.7 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
0.7 | 0.7 | GO:2000724 | regulation of cardiac vascular smooth muscle cell differentiation(GO:2000722) positive regulation of cardiac vascular smooth muscle cell differentiation(GO:2000724) |
0.7 | 0.7 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.6 | 4.4 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.6 | 3.1 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.6 | 2.5 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.6 | 0.6 | GO:0070943 | neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) |
0.6 | 3.6 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.6 | 1.8 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
0.6 | 2.4 | GO:0035502 | metanephric part of ureteric bud development(GO:0035502) |
0.6 | 2.9 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.6 | 2.9 | GO:0072181 | mesonephric duct formation(GO:0072181) |
0.6 | 2.3 | GO:0030070 | insulin processing(GO:0030070) |
0.6 | 1.7 | GO:0061090 | positive regulation of sequestering of zinc ion(GO:0061090) |
0.6 | 1.7 | GO:0072382 | minus-end-directed vesicle transport along microtubule(GO:0072382) |
0.6 | 5.6 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.6 | 3.4 | GO:0002159 | desmosome assembly(GO:0002159) |
0.6 | 1.7 | GO:0002344 | peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
0.6 | 0.6 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
0.5 | 1.6 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.5 | 1.6 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
0.5 | 1.6 | GO:0072034 | renal vesicle induction(GO:0072034) |
0.5 | 1.6 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.5 | 2.6 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.5 | 3.6 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.5 | 1.5 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.5 | 2.0 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.5 | 2.0 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.5 | 1.5 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.5 | 2.0 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.5 | 2.4 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
0.5 | 2.4 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.5 | 2.4 | GO:0070384 | Harderian gland development(GO:0070384) |
0.5 | 9.0 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.5 | 0.5 | GO:0060197 | cloacal septation(GO:0060197) |
0.5 | 1.8 | GO:0060032 | notochord regression(GO:0060032) |
0.5 | 2.3 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.5 | 1.4 | GO:0000239 | pachytene(GO:0000239) |
0.4 | 0.4 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.4 | 3.1 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.4 | 1.3 | GO:0031662 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
0.4 | 1.3 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.4 | 1.8 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
0.4 | 1.3 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.4 | 0.4 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.4 | 2.2 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.4 | 3.1 | GO:0030421 | defecation(GO:0030421) |
0.4 | 1.7 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.4 | 6.5 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.4 | 1.3 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.4 | 1.3 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.4 | 0.9 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
0.4 | 3.9 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.4 | 3.4 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.4 | 1.3 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.4 | 1.7 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.4 | 2.1 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.4 | 0.8 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.4 | 1.2 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.4 | 1.2 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
0.4 | 4.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.4 | 1.2 | GO:0071846 | actin filament debranching(GO:0071846) |
0.4 | 1.2 | GO:2000597 | optic nerve formation(GO:0021634) optic chiasma development(GO:0061360) regulation of optic nerve formation(GO:2000595) positive regulation of optic nerve formation(GO:2000597) |
0.4 | 0.8 | GO:0010957 | negative regulation of vitamin D biosynthetic process(GO:0010957) |
0.4 | 1.2 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.4 | 0.4 | GO:1904057 | negative regulation of sensory perception of pain(GO:1904057) |
0.4 | 1.6 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) regulation of vascular wound healing(GO:0061043) |
0.4 | 1.2 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
0.4 | 0.4 | GO:0035419 | activation of MAPK activity involved in innate immune response(GO:0035419) |
0.4 | 1.6 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.4 | 0.8 | GO:0072236 | metanephric loop of Henle development(GO:0072236) |
0.4 | 1.9 | GO:1900085 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
0.4 | 1.2 | GO:0045796 | negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal lipid absorption(GO:1904730) |
0.4 | 43.5 | GO:0007586 | digestion(GO:0007586) |
0.4 | 2.7 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.4 | 0.8 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.4 | 1.1 | GO:0002353 | plasma kallikrein-kinin cascade(GO:0002353) |
0.4 | 0.8 | GO:2000043 | regulation of cardiac cell fate specification(GO:2000043) |
0.4 | 0.7 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.4 | 0.4 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.4 | 1.1 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.4 | 0.7 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.4 | 1.1 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.4 | 1.4 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.3 | 1.4 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.3 | 1.4 | GO:1903896 | positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
0.3 | 3.1 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.3 | 0.3 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.3 | 1.4 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.3 | 1.4 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.3 | 1.7 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.3 | 5.2 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.3 | 2.4 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.3 | 0.3 | GO:0051794 | regulation of catagen(GO:0051794) |
0.3 | 0.7 | GO:0051885 | positive regulation of anagen(GO:0051885) |
0.3 | 3.4 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.3 | 5.4 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.3 | 1.0 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.3 | 3.0 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.3 | 3.3 | GO:0035878 | nail development(GO:0035878) |
0.3 | 0.3 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.3 | 0.3 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
0.3 | 0.6 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
0.3 | 1.0 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.3 | 1.0 | GO:0006116 | NADH oxidation(GO:0006116) |
0.3 | 4.8 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.3 | 3.2 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.3 | 1.3 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.3 | 0.3 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
0.3 | 1.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.3 | 0.3 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.3 | 0.6 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.3 | 5.1 | GO:0007614 | short-term memory(GO:0007614) |
0.3 | 0.3 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) |
0.3 | 1.5 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.3 | 3.0 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.3 | 0.9 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.3 | 10.1 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.3 | 0.3 | GO:0070100 | regulation of chemokine-mediated signaling pathway(GO:0070099) negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.3 | 0.9 | GO:0010666 | positive regulation of muscle cell apoptotic process(GO:0010661) positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.3 | 1.5 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.3 | 2.3 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.3 | 1.7 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.3 | 2.6 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.3 | 0.9 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) regulation of natural killer cell differentiation involved in immune response(GO:0032826) |
0.3 | 0.6 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.3 | 3.7 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.3 | 1.1 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.3 | 0.3 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.3 | 1.4 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.3 | 0.3 | GO:0060983 | epicardium-derived cardiac vascular smooth muscle cell differentiation(GO:0060983) |
0.3 | 0.6 | GO:0097494 | regulation of vesicle size(GO:0097494) |
0.3 | 1.1 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.3 | 1.7 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
0.3 | 0.8 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
0.3 | 1.1 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
0.3 | 0.8 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.3 | 0.5 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.3 | 0.8 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
0.3 | 0.8 | GO:0035926 | chemokine (C-C motif) ligand 2 secretion(GO:0035926) |
0.3 | 1.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.3 | 0.5 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.3 | 0.5 | GO:0072008 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.3 | 0.5 | GO:0022009 | central nervous system vasculogenesis(GO:0022009) |
0.3 | 0.3 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
0.3 | 1.6 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.3 | 0.5 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.3 | 2.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.3 | 2.1 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.3 | 1.1 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.3 | 0.8 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
0.3 | 0.3 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.3 | 1.6 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.3 | 0.8 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.3 | 2.1 | GO:0015671 | oxygen transport(GO:0015671) |
0.3 | 1.8 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.3 | 0.5 | GO:0097534 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
0.3 | 1.8 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.3 | 2.0 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.3 | 0.5 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.3 | 0.8 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.3 | 2.0 | GO:0060174 | limb bud formation(GO:0060174) |
0.3 | 0.5 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.3 | 0.8 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.2 | 1.7 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.2 | 1.2 | GO:0032901 | positive regulation of neurotrophin production(GO:0032901) |
0.2 | 1.5 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.2 | 2.5 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.2 | 0.7 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.2 | 1.0 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.2 | 1.5 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.2 | 2.5 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 1.2 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.2 | 0.7 | GO:0006592 | ornithine biosynthetic process(GO:0006592) |
0.2 | 1.0 | GO:0015825 | L-serine transport(GO:0015825) |
0.2 | 1.5 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.2 | 0.5 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 1.0 | GO:0048691 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
0.2 | 0.2 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) |
0.2 | 1.9 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.2 | 0.5 | GO:0033483 | gas homeostasis(GO:0033483) |
0.2 | 0.7 | GO:0072003 | kidney rudiment formation(GO:0072003) |
0.2 | 0.5 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.2 | 1.2 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.2 | 4.7 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.2 | 0.9 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.2 | 2.6 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.2 | 0.5 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.2 | 1.4 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.2 | 4.4 | GO:0001675 | acrosome assembly(GO:0001675) |
0.2 | 0.7 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.2 | 0.9 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.2 | 1.6 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.2 | 0.7 | GO:0070904 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.2 | 5.2 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.2 | 1.3 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.2 | 0.9 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.2 | 3.3 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.2 | 3.3 | GO:0036065 | fucosylation(GO:0036065) |
0.2 | 0.4 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.2 | 0.9 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.2 | 0.4 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
0.2 | 1.8 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 0.7 | GO:2000196 | positive regulation of female gonad development(GO:2000196) positive regulation of progesterone secretion(GO:2000872) |
0.2 | 1.5 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.2 | 0.4 | GO:0042670 | retinal cone cell differentiation(GO:0042670) |
0.2 | 0.2 | GO:0072554 | blood vessel lumenization(GO:0072554) |
0.2 | 0.9 | GO:0009816 | defense response, incompatible interaction(GO:0009814) defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
0.2 | 0.9 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
0.2 | 1.3 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.2 | 0.9 | GO:1905165 | peptidyl-aspartic acid modification(GO:0018197) regulation of lysosomal protein catabolic process(GO:1905165) |
0.2 | 3.0 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.2 | 1.5 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
0.2 | 0.6 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.2 | 0.2 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
0.2 | 0.6 | GO:0015811 | L-cystine transport(GO:0015811) |
0.2 | 1.3 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.2 | 0.6 | GO:0036509 | trimming of terminal mannose on B branch(GO:0036509) |
0.2 | 0.6 | GO:0060018 | astrocyte fate commitment(GO:0060018) hemangioblast cell differentiation(GO:0060217) |
0.2 | 0.8 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.2 | 0.4 | GO:0055093 | response to hyperoxia(GO:0055093) cellular response to hyperoxia(GO:0071455) |
0.2 | 0.4 | GO:1905146 | lysosomal protein catabolic process(GO:1905146) |
0.2 | 0.6 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
0.2 | 1.0 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 1.2 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.2 | 1.2 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.2 | 1.8 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.2 | 0.2 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.2 | 6.4 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.2 | 0.2 | GO:1903181 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
0.2 | 0.8 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.2 | 1.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 0.4 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
0.2 | 2.0 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.2 | 1.0 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.2 | 1.0 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.2 | 1.9 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.2 | 0.6 | GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.2 | 0.4 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.2 | 0.4 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) |
0.2 | 0.8 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.2 | 0.2 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.2 | 1.0 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.2 | 1.5 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.2 | 1.3 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) |
0.2 | 0.4 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.2 | 1.7 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.2 | 2.7 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.2 | 0.2 | GO:0060598 | dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
0.2 | 0.6 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.2 | 1.9 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 0.7 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.2 | 0.7 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.2 | 0.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.2 | 0.7 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
0.2 | 0.6 | GO:0061526 | acetylcholine secretion(GO:0061526) |
0.2 | 0.6 | GO:0007521 | muscle cell fate determination(GO:0007521) |
0.2 | 0.6 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.2 | 0.9 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.2 | 0.5 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.2 | 0.7 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.2 | 1.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.2 | 0.2 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.2 | 0.4 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.2 | 0.7 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.2 | 0.9 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.2 | 0.5 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.2 | 0.5 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.2 | 1.4 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.2 | 0.2 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.2 | 2.3 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.2 | 0.3 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
0.2 | 1.6 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.2 | 0.5 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.2 | 0.7 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.2 | 0.3 | GO:0060056 | mammary gland involution(GO:0060056) |
0.2 | 0.3 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.2 | 0.7 | GO:0015855 | nucleobase transport(GO:0015851) pyrimidine nucleobase transport(GO:0015855) |
0.2 | 0.5 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.2 | 1.5 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.2 | 0.3 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.2 | 1.0 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
0.2 | 1.0 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.2 | 1.5 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 1.2 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.2 | 0.5 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
0.2 | 0.3 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.2 | 1.5 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.2 | 0.5 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.2 | 1.8 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.2 | 1.3 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.2 | 1.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 0.5 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.2 | 0.3 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
0.2 | 0.8 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.2 | 0.7 | GO:0032218 | riboflavin transport(GO:0032218) |
0.2 | 0.7 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
0.2 | 0.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 1.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.2 | 0.8 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.2 | 0.5 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.2 | 0.5 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.2 | 0.5 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.2 | 0.5 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
0.2 | 1.8 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.2 | 0.8 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.2 | 0.3 | GO:0044771 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.2 | 0.8 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) regulation of NADP metabolic process(GO:1902031) |
0.2 | 0.3 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.2 | 1.6 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.2 | 0.8 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.2 | 1.9 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.2 | 0.9 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.2 | 0.3 | GO:0071395 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
0.2 | 0.9 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.2 | 0.5 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.2 | 0.8 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.2 | 4.0 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.2 | 0.9 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 1.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.2 | 1.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 1.5 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.2 | 0.5 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.2 | 0.3 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
0.2 | 0.6 | GO:0042891 | antibiotic transport(GO:0042891) |
0.2 | 0.5 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.2 | 1.2 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.2 | 0.5 | GO:0051944 | positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.2 | 0.6 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
0.2 | 0.5 | GO:0016598 | protein arginylation(GO:0016598) |
0.2 | 0.5 | GO:0002355 | detection of tumor cell(GO:0002355) |
0.2 | 0.6 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.2 | 0.3 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
0.1 | 1.0 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 1.3 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
0.1 | 0.4 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.1 | 0.6 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.1 | 0.9 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.1 | 0.4 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.1 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.1 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.1 | 2.0 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.1 | 0.7 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.7 | GO:0061438 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.1 | 0.4 | GO:0071907 | determination of pancreatic left/right asymmetry(GO:0035469) determination of digestive tract left/right asymmetry(GO:0071907) |
0.1 | 0.3 | GO:0006868 | glutamine transport(GO:0006868) |
0.1 | 0.6 | GO:0021586 | pons maturation(GO:0021586) |
0.1 | 0.3 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.1 | 0.6 | GO:0015744 | succinate transport(GO:0015744) |
0.1 | 0.6 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.1 | 0.8 | GO:0071351 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
0.1 | 0.1 | GO:0009227 | nucleotide-sugar catabolic process(GO:0009227) |
0.1 | 0.6 | GO:0036476 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.1 | 0.7 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.1 | 0.8 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 1.2 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 0.4 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.1 | 1.0 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.1 | 0.8 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
0.1 | 0.5 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.1 | 0.5 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 1.1 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.1 | 1.6 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 0.7 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.1 | 0.1 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.1 | 0.7 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
0.1 | 2.0 | GO:0001946 | lymphangiogenesis(GO:0001946) |
0.1 | 2.8 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 0.3 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 0.3 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.1 | 0.3 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.1 | 0.5 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 1.0 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 0.3 | GO:0002580 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) |
0.1 | 1.2 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.1 | 0.1 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.1 | 0.4 | GO:0060768 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 4.9 | GO:0051693 | actin filament capping(GO:0051693) |
0.1 | 1.7 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.6 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.1 | 0.1 | GO:0086068 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.1 | 0.3 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.1 | 1.0 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.1 | 0.5 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 0.3 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.1 | 0.1 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.1 | 2.0 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 0.3 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.1 | 0.6 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.1 | 0.1 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
0.1 | 0.4 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.1 | 0.5 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.1 | 0.3 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 1.3 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.1 | 0.4 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.1 | 2.3 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.1 | 0.3 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.1 | 0.4 | GO:0002268 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.1 | 0.5 | GO:0007412 | axon target recognition(GO:0007412) |
0.1 | 0.4 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.1 | 0.2 | GO:0072014 | proximal tubule development(GO:0072014) |
0.1 | 0.2 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.1 | 0.2 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.1 | 0.9 | GO:0052205 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.1 | 1.0 | GO:0032274 | gonadotropin secretion(GO:0032274) |
0.1 | 0.5 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.1 | 1.1 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.1 | 0.6 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 1.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.5 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.1 | 1.4 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.6 | GO:0032298 | positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
0.1 | 1.1 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.6 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 0.8 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.1 | 0.2 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
0.1 | 0.4 | GO:1903538 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
0.1 | 0.5 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.4 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.1 | 0.4 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.1 | 1.5 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.1 | 1.4 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.1 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.1 | 0.5 | GO:0018377 | protein myristoylation(GO:0018377) |
0.1 | 1.2 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.1 | 1.8 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.1 | 0.2 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.1 | 0.1 | GO:0010988 | regulation of low-density lipoprotein particle clearance(GO:0010988) |
0.1 | 1.2 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.1 | 0.6 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 2.0 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.1 | 1.9 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.1 | 2.2 | GO:0071467 | cellular response to pH(GO:0071467) |
0.1 | 0.4 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 1.8 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 0.8 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.1 | 0.2 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.1 | 0.6 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 0.2 | GO:0046618 | drug export(GO:0046618) |
0.1 | 0.4 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.1 | 0.4 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.1 | 0.2 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.2 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
0.1 | 0.3 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.1 | 0.3 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.1 | 1.1 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.1 | 0.3 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.1 | 2.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.1 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.1 | 0.4 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.1 | 0.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 1.5 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.1 | 0.1 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.1 | 0.7 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.9 | GO:0014841 | skeletal muscle satellite cell proliferation(GO:0014841) regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.1 | 0.2 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 1.7 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 0.4 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.1 | 0.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.2 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
0.1 | 0.4 | GO:0035799 | ureter maturation(GO:0035799) |
0.1 | 0.1 | GO:1903874 | ferrous iron transmembrane transport(GO:1903874) |
0.1 | 0.6 | GO:0061718 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.1 | 0.4 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 1.6 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.1 | 0.7 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.1 | 0.4 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.1 | 0.7 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 1.0 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.1 | 0.1 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.1 | 0.4 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.1 | 0.7 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 0.3 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.2 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.1 | 0.4 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.6 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.5 | GO:0061056 | sclerotome development(GO:0061056) |
0.1 | 0.3 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 4.6 | GO:0048678 | response to axon injury(GO:0048678) |
0.1 | 0.3 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.3 | GO:0035854 | basophil differentiation(GO:0030221) eosinophil fate commitment(GO:0035854) |
0.1 | 0.5 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.1 | 1.8 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.1 | 0.2 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 1.3 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.1 | 0.3 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 1.8 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.1 | 1.8 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 2.8 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 0.3 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.1 | 0.8 | GO:0045606 | positive regulation of epidermal cell differentiation(GO:0045606) |
0.1 | 0.4 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.1 | 0.9 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.1 | 0.3 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 0.4 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.2 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.1 | 0.2 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.1 | 0.3 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.4 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.1 | 0.4 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.1 | 0.5 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.1 | 0.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.1 | 0.4 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.1 | 0.2 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
0.1 | 0.6 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.1 | 0.1 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.1 | 2.2 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.1 | 0.6 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 0.4 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.4 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.3 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 4.3 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.1 | 0.3 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
0.1 | 0.5 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 0.3 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.1 | 0.3 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.1 | 1.6 | GO:0051923 | sulfation(GO:0051923) |
0.1 | 0.6 | GO:0097435 | fibril organization(GO:0097435) |
0.1 | 0.4 | GO:0033575 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
0.1 | 1.0 | GO:0070254 | mucus secretion(GO:0070254) |
0.1 | 0.2 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.3 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.2 | GO:0072720 | response to dithiothreitol(GO:0072720) |
0.1 | 0.3 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 1.3 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.1 | 0.6 | GO:0009251 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.1 | 1.0 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 0.5 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.1 | 0.8 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.1 | 0.3 | GO:0021564 | vagus nerve development(GO:0021564) |
0.1 | 0.3 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.1 | 0.3 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 0.3 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 1.5 | GO:0007398 | ectoderm development(GO:0007398) |
0.1 | 7.7 | GO:0090277 | positive regulation of peptide hormone secretion(GO:0090277) |
0.1 | 0.3 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.4 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.1 | 2.4 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 1.1 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 0.2 | GO:0071613 | granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
0.1 | 0.7 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 0.5 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 1.2 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.1 | 0.2 | GO:0099526 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
0.1 | 0.7 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.1 | 0.3 | GO:0061187 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.1 | 1.0 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.2 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) |
0.1 | 2.0 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.1 | 0.7 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.6 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 1.3 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.4 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.1 | 1.2 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.1 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 0.9 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.1 | 0.2 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.3 | GO:2001245 | negative regulation of cellular amine metabolic process(GO:0033239) regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.1 | 0.7 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.1 | 0.3 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.2 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.1 | 0.3 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.1 | 0.2 | GO:1900477 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
0.1 | 0.2 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) |
0.1 | 4.8 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
0.1 | 0.2 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.1 | 0.3 | GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
0.1 | 0.5 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.1 | 0.8 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.1 | 2.1 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.1 | 0.7 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.1 | 0.2 | GO:2000570 | T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
0.1 | 0.4 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.1 | 0.1 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) |
0.1 | 0.2 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 | 0.4 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.1 | 2.2 | GO:0060074 | synapse maturation(GO:0060074) |
0.1 | 0.4 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.1 | 0.3 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.1 | 0.3 | GO:0006272 | leading strand elongation(GO:0006272) |
0.1 | 0.2 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.1 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.1 | 0.2 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.1 | 0.1 | GO:0048382 | mesendoderm development(GO:0048382) corticotropin hormone secreting cell differentiation(GO:0060128) |
0.1 | 0.1 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) |
0.1 | 0.6 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.1 | 0.6 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.2 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.1 | 1.5 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.6 | GO:0098910 | T-tubule organization(GO:0033292) protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) regulation of SA node cell action potential(GO:0098907) regulation of atrial cardiac muscle cell action potential(GO:0098910) |
0.1 | 0.2 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.1 | 0.8 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.1 | 0.9 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.1 | 0.8 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 2.9 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.1 | 0.6 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.7 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.1 | 0.1 | GO:0043519 | myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
0.1 | 1.7 | GO:0003143 | embryonic heart tube morphogenesis(GO:0003143) |
0.1 | 0.1 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.5 | GO:0015809 | arginine transport(GO:0015809) |
0.1 | 0.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.5 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.2 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
0.1 | 0.1 | GO:0071726 | response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
0.1 | 0.3 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.1 | 0.1 | GO:0032423 | regulation of mismatch repair(GO:0032423) |
0.1 | 0.1 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.1 | GO:0009405 | pathogenesis(GO:0009405) |
0.1 | 0.3 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.1 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.1 | 0.4 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.1 | 0.1 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.1 | 0.1 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.1 | 0.1 | GO:0060168 | regulation of adenosine receptor signaling pathway(GO:0060167) positive regulation of adenosine receptor signaling pathway(GO:0060168) regulation of G-protein coupled receptor internalization(GO:1904020) |
0.1 | 0.2 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.1 | 0.6 | GO:0036503 | ERAD pathway(GO:0036503) |
0.1 | 0.4 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine salvage(GO:0071267) |
0.1 | 0.2 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.1 | 2.1 | GO:0046677 | response to antibiotic(GO:0046677) |
0.1 | 0.2 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.1 | 0.2 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.1 | 0.6 | GO:0030325 | adrenal gland development(GO:0030325) |
0.1 | 0.1 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.1 | 0.6 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.1 | 0.2 | GO:0035087 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.1 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.1 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.1 | 1.1 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 0.3 | GO:0006833 | water transport(GO:0006833) |
0.1 | 0.3 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.1 | 0.3 | GO:0097503 | sialylation(GO:0097503) |
0.1 | 0.7 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.1 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.4 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.1 | 1.8 | GO:1901184 | regulation of ERBB signaling pathway(GO:1901184) |
0.1 | 0.2 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.1 | 0.1 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.1 | 0.1 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 0.2 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.1 | 0.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.6 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.6 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.3 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 2.6 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.1 | 0.3 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.1 | 0.2 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.1 | 0.2 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.1 | 0.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.2 | GO:1903632 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
0.1 | 0.5 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.4 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) |
0.1 | 0.1 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) |
0.1 | 0.2 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) pyrimidine nucleoside catabolic process(GO:0046135) |
0.1 | 0.3 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 0.9 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.5 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 2.4 | GO:0006909 | phagocytosis(GO:0006909) |
0.1 | 0.5 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.1 | 0.2 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.1 | 1.3 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.1 | 1.0 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.9 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.1 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.1 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.1 | 0.3 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.1 | 0.2 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.1 | 0.5 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.1 | 0.2 | GO:0007314 | oocyte construction(GO:0007308) oocyte axis specification(GO:0007309) oocyte anterior/posterior axis specification(GO:0007314) pole plasm assembly(GO:0007315) maternal determination of anterior/posterior axis, embryo(GO:0008358) P granule organization(GO:0030719) |
0.1 | 0.3 | GO:0042730 | fibrinolysis(GO:0042730) |
0.1 | 0.5 | GO:0015879 | carnitine transport(GO:0015879) |
0.1 | 0.4 | GO:0034390 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.1 | 0.1 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.1 | 0.9 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.3 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.1 | 0.1 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.1 | 1.2 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.4 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.1 | 0.4 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.1 | 3.7 | GO:0006821 | chloride transport(GO:0006821) |
0.1 | 0.6 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.2 | GO:0042275 | error-free postreplication DNA repair(GO:0042275) |
0.1 | 0.5 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 0.2 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.4 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.1 | 0.3 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.1 | 1.4 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 0.1 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.1 | 0.1 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.0 | 0.3 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.2 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 0.2 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.0 | 0.1 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.0 | 0.2 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.0 | 0.1 | GO:0015881 | creatine transport(GO:0015881) |
0.0 | 0.0 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.0 | 0.4 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.0 | 0.2 | GO:0051715 | cytolysis in other organism(GO:0051715) |
0.0 | 2.5 | GO:0045807 | positive regulation of endocytosis(GO:0045807) |
0.0 | 1.3 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
0.0 | 0.2 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.0 | 0.1 | GO:0048880 | medulla oblongata development(GO:0021550) hindbrain tangential cell migration(GO:0021934) sensory system development(GO:0048880) |
0.0 | 0.2 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.0 | 0.1 | GO:0021933 | radial glia guided migration of cerebellar granule cell(GO:0021933) |
0.0 | 0.1 | GO:0000915 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
0.0 | 1.5 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.0 | 0.5 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.6 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.0 | 0.3 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.0 | 0.3 | GO:0072537 | fibroblast activation(GO:0072537) |
0.0 | 0.1 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.0 | 0.0 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.0 | 0.2 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.0 | 0.1 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.0 | 0.2 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.0 | 0.5 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.0 | 0.5 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 0.7 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.6 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.0 | 1.2 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.5 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
0.0 | 0.1 | GO:1904579 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
0.0 | 0.4 | GO:0044257 | cellular protein catabolic process(GO:0044257) |
0.0 | 0.3 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.0 | 0.2 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.8 | GO:0003016 | respiratory system process(GO:0003016) |
0.0 | 0.2 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
0.0 | 0.9 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.0 | 0.2 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.0 | 0.1 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
0.0 | 0.0 | GO:0032439 | endosome localization(GO:0032439) |
0.0 | 0.6 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.7 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 0.4 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.0 | 0.1 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
0.0 | 0.1 | GO:1990918 | double-strand break repair involved in meiotic recombination(GO:1990918) |
0.0 | 0.1 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.0 | 0.2 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.0 | 0.0 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.0 | 2.6 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.0 | 0.4 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.0 | 0.1 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.2 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.0 | 0.1 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.0 | 0.4 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.0 | 0.2 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.0 | 4.5 | GO:0006006 | glucose metabolic process(GO:0006006) |
0.0 | 0.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.1 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.0 | 0.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.0 | 0.1 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.0 | 0.6 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
0.0 | 0.2 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.0 | 0.1 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.0 | 0.2 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.0 | 0.1 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.0 | 0.2 | GO:0051709 | regulation of killing of cells of other organism(GO:0051709) |
0.0 | 1.1 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.4 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.0 | 0.1 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
0.0 | 0.5 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.0 | 0.1 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
0.0 | 0.3 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.0 | 0.6 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.2 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.0 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.5 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.0 | 0.1 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
0.0 | 0.4 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.0 | 0.1 | GO:0010226 | response to lithium ion(GO:0010226) cellular response to lithium ion(GO:0071285) |
0.0 | 0.3 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.0 | 0.2 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.5 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.0 | 0.2 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
0.0 | 0.1 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.0 | 0.1 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.0 | 0.7 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.0 | 0.1 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.0 | 0.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.0 | 0.1 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.0 | 0.0 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.0 | 0.0 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.0 | 0.1 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.0 | 0.2 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.8 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.3 | GO:0045598 | regulation of fat cell differentiation(GO:0045598) |
0.0 | 0.1 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.0 | 0.1 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.0 | 0.7 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.0 | 0.4 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.0 | 0.4 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 0.7 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.0 | 0.1 | GO:0031620 | regulation of fever generation(GO:0031620) |
0.0 | 0.8 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.2 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
0.0 | 0.2 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 0.3 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.1 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.1 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.0 | 0.8 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.1 | GO:0035268 | protein mannosylation(GO:0035268) |
0.0 | 0.0 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.0 | 0.2 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.1 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.0 | 0.2 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.0 | 1.0 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.0 | 0.7 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) |
0.0 | 0.5 | GO:0042102 | positive regulation of T cell proliferation(GO:0042102) |
0.0 | 0.3 | GO:1990403 | embryonic brain development(GO:1990403) |
0.0 | 0.3 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.0 | 0.3 | GO:0090335 | regulation of brown fat cell differentiation(GO:0090335) |
0.0 | 0.4 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.5 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.0 | 0.2 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 0.2 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
0.0 | 0.3 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.0 | 0.4 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.0 | 0.2 | GO:0036003 | positive regulation of transcription from RNA polymerase II promoter in response to stress(GO:0036003) |
0.0 | 3.0 | GO:0050953 | sensory perception of light stimulus(GO:0050953) |
0.0 | 0.0 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.0 | 0.7 | GO:0050728 | negative regulation of inflammatory response(GO:0050728) |
0.0 | 0.6 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 0.7 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.0 | 0.0 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.0 | 0.3 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.7 | GO:0071514 | genetic imprinting(GO:0071514) |
0.0 | 0.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.2 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.2 | GO:0046697 | decidualization(GO:0046697) |
0.0 | 0.1 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.0 | 0.2 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.0 | 0.4 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.1 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.0 | 0.1 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.0 | 0.1 | GO:0061525 | hindgut development(GO:0061525) |
0.0 | 0.1 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
0.0 | 0.2 | GO:2000758 | positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.0 | 0.1 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.0 | 0.2 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) |
0.0 | 0.3 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.0 | 0.2 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.2 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.0 | 0.2 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.0 | 0.2 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.0 | 0.1 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.0 | 0.4 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.0 | 0.2 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.0 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.0 | 0.1 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.0 | 0.5 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.1 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.0 | 0.1 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.0 | 0.3 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.5 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.0 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) |
0.0 | 0.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.4 | GO:0007422 | peripheral nervous system development(GO:0007422) |
0.0 | 0.7 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 0.1 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.0 | 0.2 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.0 | 0.2 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.1 | GO:0021546 | rhombomere development(GO:0021546) |
0.0 | 0.0 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.0 | 0.0 | GO:0072395 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.0 | 0.2 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.3 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.7 | GO:0030166 | proteoglycan biosynthetic process(GO:0030166) |
0.0 | 0.1 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.0 | 0.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.0 | 0.1 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.0 | 0.5 | GO:0070527 | platelet aggregation(GO:0070527) |
0.0 | 0.7 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.0 | 0.2 | GO:0032506 | cytokinetic process(GO:0032506) |
0.0 | 0.0 | GO:0035933 | glucocorticoid secretion(GO:0035933) regulation of glucocorticoid secretion(GO:2000849) |
0.0 | 0.2 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.0 | 0.1 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
0.0 | 0.2 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.0 | 0.0 | GO:1902571 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.1 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.0 | 0.0 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.0 | 0.2 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.2 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.0 | 0.5 | GO:0048821 | erythrocyte development(GO:0048821) |
0.0 | 0.1 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.0 | 0.1 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.0 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.1 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.0 | 0.0 | GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
0.0 | 0.2 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.0 | 0.1 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.0 | 0.3 | GO:0097320 | membrane tubulation(GO:0097320) |
0.0 | 0.0 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.0 | 0.1 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.0 | 0.1 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
0.0 | 0.1 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.0 | 0.2 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.0 | 0.1 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.4 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.1 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.0 | 0.2 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.0 | 0.1 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.3 | GO:0061180 | mammary gland epithelium development(GO:0061180) |
0.0 | 1.2 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
0.0 | 0.0 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.0 | 0.2 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.0 | 0.3 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.0 | 0.5 | GO:0006073 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.0 | 0.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.1 | GO:0071549 | response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
0.0 | 0.0 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.0 | 0.1 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.0 | 0.2 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.0 | 0.1 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.0 | 0.5 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 0.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.0 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.0 | 0.0 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.0 | 0.0 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.0 | 0.3 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.1 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.0 | 0.1 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.0 | 0.0 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.0 | 0.0 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.0 | 0.0 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.0 | 0.0 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.0 | 0.1 | GO:0060746 | parental behavior(GO:0060746) |
0.0 | 0.0 | GO:0042737 | drug catabolic process(GO:0042737) |
0.0 | 0.0 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.0 | 0.1 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.0 | 0.2 | GO:0021983 | pituitary gland development(GO:0021983) |
0.0 | 1.0 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.0 | 0.1 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.0 | 0.1 | GO:0048255 | mRNA stabilization(GO:0048255) |
0.0 | 0.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.2 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
0.0 | 0.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.0 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.0 | 0.1 | GO:2000757 | negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.0 | 0.1 | GO:0035247 | peptidyl-arginine N-methylation(GO:0035246) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.0 | 0.1 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.0 | 0.2 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.0 | 16.8 | GO:0006508 | proteolysis(GO:0006508) |
0.0 | 0.1 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.0 | 0.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.1 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.0 | GO:0015865 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
0.0 | 0.2 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.1 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.0 | 0.0 | GO:0046710 | GDP metabolic process(GO:0046710) |
0.0 | 0.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.1 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.0 | 0.0 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.0 | 0.0 | GO:0036451 | cap mRNA methylation(GO:0036451) |
0.0 | 0.0 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.0 | 0.0 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) positive regulation of leukocyte apoptotic process(GO:2000108) |
0.0 | 0.1 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.0 | 0.0 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.0 | 0.0 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 0.0 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.0 | 0.0 | GO:1905038 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
0.0 | 0.0 | GO:0009223 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 5.9 | GO:0061689 | tricellular tight junction(GO:0061689) |
1.0 | 1.9 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.8 | 2.3 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.7 | 2.8 | GO:0044218 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.7 | 2.7 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.7 | 2.0 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.7 | 2.6 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.6 | 1.9 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
0.6 | 2.3 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.6 | 1.7 | GO:0005605 | basal lamina(GO:0005605) |
0.6 | 9.9 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.5 | 2.7 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.5 | 2.2 | GO:0071953 | elastic fiber(GO:0071953) |
0.5 | 16.2 | GO:0042588 | zymogen granule(GO:0042588) |
0.5 | 2.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.5 | 1.4 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.5 | 1.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.5 | 2.7 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.4 | 0.8 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.4 | 1.6 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.4 | 3.6 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.4 | 8.0 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.4 | 1.2 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
0.4 | 2.7 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.4 | 1.2 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.4 | 0.4 | GO:1902737 | dendritic filopodium(GO:1902737) |
0.4 | 1.5 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.4 | 2.6 | GO:0008091 | spectrin(GO:0008091) |
0.4 | 9.6 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.4 | 8.1 | GO:0032426 | stereocilium tip(GO:0032426) |
0.3 | 1.7 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.3 | 2.4 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.3 | 1.7 | GO:0005914 | spot adherens junction(GO:0005914) |
0.3 | 0.7 | GO:0042583 | chromaffin granule(GO:0042583) |
0.3 | 1.3 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.3 | 3.8 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.3 | 1.4 | GO:1990923 | PET complex(GO:1990923) |
0.3 | 1.1 | GO:0098888 | extrinsic component of presynaptic membrane(GO:0098888) |
0.3 | 1.4 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.3 | 0.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.3 | 1.5 | GO:0019814 | immunoglobulin complex(GO:0019814) |
0.3 | 3.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.3 | 6.0 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.2 | 1.0 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.2 | 2.8 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 1.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.2 | 0.7 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.2 | 6.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 11.2 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.2 | 0.7 | GO:1990423 | RZZ complex(GO:1990423) |
0.2 | 5.8 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.2 | 3.9 | GO:0005861 | troponin complex(GO:0005861) |
0.2 | 1.5 | GO:0097444 | spine apparatus(GO:0097444) |
0.2 | 1.1 | GO:0097361 | CIA complex(GO:0097361) |
0.2 | 2.1 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 3.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 0.6 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
0.2 | 1.2 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.2 | 1.0 | GO:0097443 | sorting endosome(GO:0097443) |
0.2 | 10.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 0.6 | GO:0036125 | mitochondrial fatty acid beta-oxidation multienzyme complex(GO:0016507) fatty acid beta-oxidation multienzyme complex(GO:0036125) |
0.2 | 1.7 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.2 | 0.9 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 1.4 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 2.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 1.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.2 | 13.2 | GO:0005844 | polysome(GO:0005844) |
0.2 | 2.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 0.7 | GO:0031310 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
0.2 | 3.8 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.2 | 1.0 | GO:0035976 | AP1 complex(GO:0035976) |
0.2 | 5.9 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.2 | 0.5 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.2 | 4.0 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 0.5 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 0.8 | GO:0071914 | prominosome(GO:0071914) |
0.2 | 0.3 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.2 | 1.9 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.2 | 1.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 1.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.2 | 0.6 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 3.0 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.4 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.1 | 0.6 | GO:0099522 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
0.1 | 2.1 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.4 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.1 | 0.4 | GO:0038045 | large latent transforming growth factor-beta complex(GO:0038045) |
0.1 | 1.1 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 1.0 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.5 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 1.8 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 5.6 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 0.8 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 0.4 | GO:0005940 | septin ring(GO:0005940) |
0.1 | 1.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 4.8 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 1.4 | GO:0016011 | dystroglycan complex(GO:0016011) |
0.1 | 0.3 | GO:0044393 | microspike(GO:0044393) |
0.1 | 0.4 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.1 | 2.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 213.2 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 0.5 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 1.6 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 0.4 | GO:0034657 | GID complex(GO:0034657) |
0.1 | 0.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 1.6 | GO:0070069 | cytochrome complex(GO:0070069) |
0.1 | 0.7 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 2.5 | GO:0005865 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
0.1 | 0.9 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.4 | GO:0014802 | terminal cisterna(GO:0014802) |
0.1 | 0.2 | GO:0044305 | calyx of Held(GO:0044305) |
0.1 | 0.8 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 0.3 | GO:0018444 | translation release factor complex(GO:0018444) |
0.1 | 2.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 1.2 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 0.2 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.5 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.1 | 0.7 | GO:0001740 | Barr body(GO:0001740) |
0.1 | 0.3 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.1 | 0.3 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.1 | 0.8 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 0.4 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.1 | 1.5 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 2.9 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 1.6 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 1.4 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 4.4 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.7 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 0.5 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 1.3 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.1 | 0.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.7 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 2.5 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.2 | GO:0098842 | postsynaptic early endosome(GO:0098842) |
0.1 | 0.4 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 0.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.4 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 0.5 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 0.2 | GO:1990696 | USH2 complex(GO:1990696) |
0.1 | 2.4 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 1.1 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.4 | GO:0097227 | sperm annulus(GO:0097227) |
0.1 | 4.4 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 2.8 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.4 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 1.2 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.2 | GO:1903349 | omegasome membrane(GO:1903349) |
0.1 | 0.2 | GO:0098855 | HCN channel complex(GO:0098855) |
0.1 | 0.6 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.1 | 3.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.4 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) lumenal side of membrane(GO:0098576) |
0.1 | 5.6 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 0.4 | GO:1990357 | terminal web(GO:1990357) |
0.1 | 2.7 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.1 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 0.5 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 0.1 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.4 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 0.2 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 0.2 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 1.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 1.1 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.2 | GO:0005745 | m-AAA complex(GO:0005745) |
0.1 | 0.5 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 0.2 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.1 | 0.2 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.1 | 0.5 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 0.4 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 0.2 | GO:0035841 | growing cell tip(GO:0035838) new growing cell tip(GO:0035841) |
0.1 | 0.5 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.1 | 0.1 | GO:1902710 | GABA receptor complex(GO:1902710) |
0.1 | 0.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.2 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.0 | 0.7 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.2 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.0 | 0.1 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.5 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 0.2 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.0 | 0.4 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.2 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.0 | 0.1 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) ATPase dependent transmembrane transport complex(GO:0098533) |
0.0 | 0.4 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.1 | GO:0071007 | U2-type catalytic step 2 spliceosome(GO:0071007) |
0.0 | 0.3 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 2.6 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.7 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 0.4 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 4.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.3 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.3 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 0.3 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 0.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.2 | GO:1990415 | Pex17p-Pex14p docking complex(GO:1990415) peroxisomal importomer complex(GO:1990429) |
0.0 | 46.6 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.0 | 1.2 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 3.6 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.3 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.7 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.1 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.0 | 0.1 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.0 | 1.5 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 2.8 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 0.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.1 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.0 | 1.3 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.0 | 0.0 | GO:0019034 | viral replication complex(GO:0019034) |
0.0 | 2.5 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.0 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.0 | 1.1 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.3 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.1 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.0 | 0.4 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.0 | 0.1 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.0 | 0.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.0 | 0.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 0.4 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 2.1 | GO:0032432 | actin filament bundle(GO:0032432) |
0.0 | 0.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.0 | 2.3 | GO:0005930 | axoneme(GO:0005930) |
0.0 | 0.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.0 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 0.1 | GO:1990246 | uniplex complex(GO:1990246) |
0.0 | 0.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.3 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.0 | 0.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 1.5 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.4 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 0.1 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 0.2 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.1 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 0.1 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.1 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.0 | 0.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.0 | 0.7 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.0 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.0 | GO:0016460 | myosin II complex(GO:0016460) |
0.0 | 0.6 | GO:0043679 | axon terminus(GO:0043679) |
0.0 | 0.7 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.2 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 6.1 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.2 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 0.1 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 0.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.0 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 0.1 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.0 | 0.2 | GO:0031932 | TORC2 complex(GO:0031932) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.8 | 11.5 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
1.6 | 9.8 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
1.6 | 6.5 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
1.4 | 11.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.4 | 4.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
1.4 | 9.6 | GO:0005499 | vitamin D binding(GO:0005499) |
1.3 | 15.1 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
1.3 | 8.8 | GO:0004556 | alpha-amylase activity(GO:0004556) |
1.2 | 8.1 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
1.1 | 5.5 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
1.0 | 3.0 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
1.0 | 3.8 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
0.9 | 9.4 | GO:0035473 | lipase binding(GO:0035473) |
0.9 | 3.4 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
0.8 | 6.3 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.8 | 2.4 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.8 | 3.0 | GO:0016708 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
0.7 | 3.0 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.7 | 2.2 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.7 | 9.7 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.7 | 2.1 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.7 | 7.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.7 | 2.7 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.6 | 3.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.6 | 1.8 | GO:0070737 | protein-glycine ligase activity, elongating(GO:0070737) |
0.6 | 12.7 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.6 | 2.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.5 | 17.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.5 | 1.6 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
0.5 | 1.6 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.5 | 1.6 | GO:0032190 | acrosin binding(GO:0032190) |
0.5 | 1.5 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.5 | 12.4 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.5 | 0.5 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.5 | 2.0 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.4 | 92.1 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.4 | 4.0 | GO:0033691 | sialic acid binding(GO:0033691) |
0.4 | 2.2 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.4 | 1.3 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.4 | 1.7 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.4 | 3.9 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.4 | 1.3 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
0.4 | 1.3 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.4 | 1.2 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.4 | 1.7 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.4 | 1.2 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.4 | 2.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.4 | 2.9 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.4 | 2.5 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.4 | 1.6 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.4 | 23.0 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.4 | 6.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.4 | 0.4 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.4 | 1.6 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.4 | 1.9 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.4 | 1.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.4 | 1.1 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.4 | 1.8 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.4 | 1.5 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.4 | 1.5 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.4 | 1.1 | GO:0046592 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
0.4 | 1.1 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.4 | 1.1 | GO:0045159 | myosin II binding(GO:0045159) |
0.4 | 2.8 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.4 | 1.1 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.3 | 3.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.3 | 1.0 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.3 | 0.7 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.3 | 1.7 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.3 | 0.7 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.3 | 0.3 | GO:0031692 | alpha-1A adrenergic receptor binding(GO:0031691) alpha-1B adrenergic receptor binding(GO:0031692) follicle-stimulating hormone receptor binding(GO:0031762) |
0.3 | 1.3 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.3 | 4.6 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.3 | 1.3 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.3 | 6.5 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.3 | 2.3 | GO:0031013 | troponin I binding(GO:0031013) |
0.3 | 1.3 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.3 | 1.9 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.3 | 0.9 | GO:0005302 | L-tyrosine transmembrane transporter activity(GO:0005302) |
0.3 | 2.5 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.3 | 0.9 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.3 | 3.3 | GO:0016918 | retinal binding(GO:0016918) |
0.3 | 2.7 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.3 | 5.4 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.3 | 1.2 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.3 | 1.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.3 | 0.9 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.3 | 0.9 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.3 | 2.4 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.3 | 8.2 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.3 | 0.9 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.3 | 2.9 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.3 | 4.0 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.3 | 4.3 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.3 | 0.8 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.3 | 8.5 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.3 | 2.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.3 | 1.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.3 | 2.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.3 | 1.7 | GO:1903763 | gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
0.3 | 2.8 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.3 | 1.4 | GO:0034584 | piRNA binding(GO:0034584) |
0.3 | 2.7 | GO:0039706 | co-receptor binding(GO:0039706) |
0.3 | 0.8 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.3 | 2.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.3 | 2.9 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.3 | 9.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.3 | 7.4 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.3 | 2.1 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.3 | 1.3 | GO:1990254 | keratin filament binding(GO:1990254) |
0.3 | 7.4 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.3 | 1.0 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.3 | 1.3 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.3 | 4.8 | GO:0001618 | virus receptor activity(GO:0001618) |
0.3 | 1.8 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 0.7 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.2 | 2.0 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.2 | 0.7 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.2 | 1.9 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.2 | 1.2 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 0.7 | GO:0017084 | glutamate 5-kinase activity(GO:0004349) glutamate-5-semialdehyde dehydrogenase activity(GO:0004350) delta1-pyrroline-5-carboxylate synthetase activity(GO:0017084) amino acid kinase activity(GO:0019202) |
0.2 | 2.6 | GO:0051861 | glycolipid binding(GO:0051861) |
0.2 | 0.7 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.2 | 0.7 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.2 | 1.4 | GO:0015265 | urea channel activity(GO:0015265) |
0.2 | 0.2 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.2 | 0.7 | GO:0015229 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.2 | 2.9 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 0.7 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.2 | 4.7 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.2 | 1.3 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 1.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 0.7 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.2 | 0.9 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
0.2 | 1.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 0.8 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.2 | 0.8 | GO:2001069 | glycogen binding(GO:2001069) |
0.2 | 0.6 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.2 | 0.8 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.2 | 2.3 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 0.6 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.2 | 1.4 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.2 | 0.4 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.2 | 1.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 2.0 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.2 | 1.4 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.2 | 2.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 7.2 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.2 | 3.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 1.6 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.2 | 0.6 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.2 | 0.8 | GO:0004092 | carnitine O-acetyltransferase activity(GO:0004092) |
0.2 | 0.6 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.2 | 0.8 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 0.4 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.2 | 0.4 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.2 | 1.9 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 2.0 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.2 | 1.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.2 | 0.2 | GO:0055100 | adiponectin binding(GO:0055100) |
0.2 | 0.4 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.2 | 0.5 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.2 | 1.1 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.2 | 1.1 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 1.3 | GO:0019864 | IgG binding(GO:0019864) |
0.2 | 0.5 | GO:0045353 | interleukin-1, Type II receptor binding(GO:0005151) interleukin-1 Type I receptor antagonist activity(GO:0045352) interleukin-1 Type II receptor antagonist activity(GO:0045353) |
0.2 | 1.1 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.2 | 2.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.2 | 1.4 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 0.5 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.2 | 0.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 0.9 | GO:0008142 | oxysterol binding(GO:0008142) |
0.2 | 0.7 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.2 | 1.7 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 1.2 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.2 | 1.9 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 1.2 | GO:0048101 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.2 | 3.4 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.2 | 0.5 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.2 | 0.7 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.2 | 1.0 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.2 | 0.5 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.2 | 0.7 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.2 | 1.9 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.2 | 2.6 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.2 | 1.8 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 0.6 | GO:0005124 | scavenger receptor binding(GO:0005124) |
0.2 | 0.5 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 1.6 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.2 | 0.3 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
0.2 | 4.3 | GO:0030506 | ankyrin binding(GO:0030506) |
0.2 | 2.8 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.2 | 1.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.2 | 2.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.2 | 0.6 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 2.4 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 3.3 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 0.4 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.1 | 0.3 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 1.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.6 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.1 | 2.6 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 1.6 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.4 | GO:0042936 | dipeptide transporter activity(GO:0042936) |
0.1 | 0.7 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 0.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.6 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.7 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.7 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 2.4 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 2.0 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.6 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.1 | 1.3 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.4 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
0.1 | 0.6 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.4 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.1 | 2.6 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 1.2 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.4 | GO:0042806 | fucose binding(GO:0042806) |
0.1 | 0.4 | GO:0071820 | N-box binding(GO:0071820) |
0.1 | 2.2 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.8 | GO:0045340 | mercury ion binding(GO:0045340) |
0.1 | 0.9 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 3.0 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 0.4 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
0.1 | 1.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.5 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.1 | 2.5 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 2.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.5 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 0.8 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 0.4 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.1 | 0.4 | GO:0030629 | U6 snRNA 3'-end binding(GO:0030629) |
0.1 | 2.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.7 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 0.4 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.1 | 1.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 0.5 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.7 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 0.8 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.5 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.1 | 2.0 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.5 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.2 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 4.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.9 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 12.3 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 1.4 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.1 | 15.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.3 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.1 | 0.9 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 0.3 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.6 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.1 | 0.5 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.7 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 1.2 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 1.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.9 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.1 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 0.3 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.1 | 0.5 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.1 | 1.7 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 0.2 | GO:0048030 | disaccharide binding(GO:0048030) |
0.1 | 0.2 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.1 | 0.2 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.1 | 2.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.4 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.1 | 4.5 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.5 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.1 | 1.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.8 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 0.8 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 0.4 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.1 | 0.3 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 1.0 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.4 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.1 | 0.4 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.1 | 1.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 1.7 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.1 | 1.4 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.1 | 0.4 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.4 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 1.9 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 4.3 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.1 | 0.3 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 0.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.8 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.7 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 0.3 | GO:0033699 | DNA 5'-adenosine monophosphate hydrolase activity(GO:0033699) |
0.1 | 0.7 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 0.6 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 0.5 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 0.4 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.1 | 4.4 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.1 | 0.4 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.3 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 11.4 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 0.4 | GO:0009384 | N-acylmannosamine kinase activity(GO:0009384) |
0.1 | 0.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 0.3 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.1 | 0.4 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.1 | 0.3 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.1 | 0.7 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 0.7 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 2.3 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 0.3 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.1 | 0.9 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.1 | 0.3 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.1 | 0.4 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.3 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.1 | 0.3 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.1 | 0.3 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.1 | GO:0019981 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
0.1 | 0.3 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 1.9 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.2 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 0.6 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 0.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.2 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.1 | 1.7 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 3.2 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.6 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 2.3 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.1 | 0.7 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.9 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 0.5 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 0.1 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 1.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 3.0 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.2 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 0.4 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.7 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.1 | 1.1 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.4 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.1 | 0.7 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.3 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 1.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.2 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.1 | 0.6 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.2 | GO:0030519 | snoRNP binding(GO:0030519) |
0.1 | 0.3 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 0.4 | GO:0001030 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.1 | 0.8 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.4 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.1 | 0.3 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.1 | 0.3 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 1.0 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 1.3 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 0.5 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
0.1 | 0.3 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 1.5 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 0.3 | GO:0070976 | TIR domain binding(GO:0070976) |
0.1 | 0.3 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 2.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 0.2 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
0.1 | 0.3 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.3 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.1 | 0.3 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 0.9 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.2 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.1 | 0.1 | GO:1904315 | transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.1 | 0.3 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.1 | 0.4 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 2.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.9 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.1 | 0.5 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.1 | 0.8 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 0.1 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.1 | 1.2 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 2.0 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.1 | 0.3 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.2 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.1 | 0.2 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.2 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.1 | 0.1 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
0.1 | 0.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 1.1 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.3 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 0.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 1.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.8 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.7 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.2 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.1 | 0.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 1.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.4 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.5 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 2.1 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.2 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 0.3 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.0 | 0.2 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 3.6 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 1.4 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.1 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.1 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.0 | 0.2 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.0 | 0.2 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.0 | 0.6 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.1 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.0 | 0.3 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.0 | 0.1 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
0.0 | 0.1 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.0 | 0.5 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.6 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.0 | 0.5 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 14.1 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.0 | 0.2 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.0 | 1.6 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.1 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
0.0 | 0.4 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.0 | 0.2 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 1.7 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.2 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.1 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 0.8 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.3 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.0 | 0.2 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.3 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.0 | 0.3 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.0 | 0.3 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
0.0 | 0.5 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.1 | GO:0002054 | nucleobase binding(GO:0002054) |
0.0 | 0.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 2.6 | GO:0005254 | chloride channel activity(GO:0005254) |
0.0 | 0.5 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.1 | GO:0098973 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
0.0 | 1.4 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.2 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.2 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 0.7 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) phospholipase C activity(GO:0004629) |
0.0 | 0.8 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.3 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.0 | 0.1 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.0 | 0.6 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.0 | 0.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.2 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 0.2 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.0 | 0.1 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.0 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.0 | 0.4 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.1 | GO:0043532 | angiostatin binding(GO:0043532) |
0.0 | 0.1 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.0 | 0.9 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.4 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.0 | 0.1 | GO:0050436 | microfibril binding(GO:0050436) |
0.0 | 0.3 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.1 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.0 | 0.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.1 | GO:0051425 | PTB domain binding(GO:0051425) |
0.0 | 0.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.4 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.3 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.3 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.0 | 1.0 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 0.2 | GO:0042887 | amide transmembrane transporter activity(GO:0042887) |
0.0 | 0.2 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.5 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.0 | 3.1 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.0 | 0.2 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.0 | 0.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.2 | GO:0019808 | polyamine binding(GO:0019808) |
0.0 | 0.2 | GO:1990188 | euchromatin binding(GO:1990188) |
0.0 | 0.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.4 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.0 | 0.1 | GO:0070279 | vitamin B6 binding(GO:0070279) |
0.0 | 1.9 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.1 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.0 | 0.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.1 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.0 | 0.1 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.0 | 0.1 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.0 | 0.1 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.0 | 0.1 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.2 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.0 | 0.2 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.0 | 0.1 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.0 | 0.1 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.0 | 0.2 | GO:0009374 | biotin binding(GO:0009374) |
0.0 | 0.1 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.0 | 0.1 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.0 | 0.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.2 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.0 | 0.1 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.0 | 0.1 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.0 | 0.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.4 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.0 | 0.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.1 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.0 | 0.1 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.0 | 0.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.1 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
0.0 | 0.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 1.2 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.2 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.7 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.1 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.0 | 0.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.1 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.0 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.1 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 1.3 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.0 | 0.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.0 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.0 | 0.2 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.0 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.0 | 0.0 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.0 | 0.1 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
0.0 | 0.1 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.0 | 0.0 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.1 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.1 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.0 | 0.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 0.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.6 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.7 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 0.0 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.0 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.0 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.1 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.1 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.0 | 0.1 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.0 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.0 | 0.1 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 2.0 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.0 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.0 | 0.0 | GO:0005118 | sevenless binding(GO:0005118) |
0.0 | 0.2 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.0 | 0.0 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
0.0 | 0.0 | GO:0046997 | oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.0 | 0.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.6 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.0 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.0 | GO:0031404 | chloride ion binding(GO:0031404) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 7.3 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.4 | 0.4 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.3 | 13.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.3 | 2.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 50.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 4.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 1.5 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 2.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 1.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 32.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 3.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 13.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 3.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 3.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 1.7 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 4.7 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 8.3 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 4.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.8 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 1.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 7.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 21.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 3.7 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.8 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 1.3 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 3.8 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.1 | 0.5 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 2.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 6.8 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 1.6 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 1.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 0.4 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 2.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 1.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 2.4 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 0.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 25.2 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 1.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 2.1 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 0.6 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 1.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 1.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.6 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 3.2 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 0.2 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 0.3 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 1.1 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 0.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 1.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 1.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 1.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 3.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 3.4 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 1.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 1.0 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 1.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 2.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 1.6 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 1.8 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 2.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 1.9 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 1.7 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 3.5 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 1.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 1.9 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.3 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.4 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.4 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.9 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.3 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 1.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.4 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.0 | 0.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 2.0 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.9 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 1.9 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.5 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 2.0 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 1.0 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.8 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.3 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.2 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.0 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.0 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 15.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.7 | 18.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.5 | 24.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.5 | 1.6 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.5 | 5.9 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.5 | 9.0 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.4 | 1.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.4 | 3.0 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.4 | 8.5 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.4 | 7.0 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.3 | 13.0 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.3 | 7.0 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.3 | 5.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.3 | 3.9 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.3 | 4.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 3.7 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.2 | 3.2 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.2 | 3.4 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.2 | 4.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 0.4 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 4.3 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.2 | 2.8 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 21.5 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.2 | 2.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 7.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 1.5 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.2 | 5.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 3.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.2 | 0.8 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 1.6 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 4.1 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 5.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 3.6 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 0.9 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 4.5 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 5.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 8.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 7.3 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 0.4 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.1 | 2.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 1.1 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.1 | 0.8 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 3.2 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 9.1 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 1.6 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 0.1 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
0.1 | 1.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 2.7 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 2.5 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 4.9 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 1.7 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 0.2 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.1 | 2.2 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.1 | 1.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 1.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.3 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 0.6 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 1.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 1.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 6.9 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.1 | 1.4 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 0.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 0.6 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.4 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.1 | 1.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 7.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 2.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.7 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 1.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 1.8 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.1 | 4.9 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 2.2 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 0.9 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 2.0 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.5 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 0.3 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.1 | 4.2 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 0.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 0.1 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.1 | 0.1 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.1 | 3.5 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 2.9 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.3 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.1 | 0.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 5.1 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 1.2 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 1.2 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 0.1 | REACTOME NUCLEOTIDE EXCISION REPAIR | Genes involved in Nucleotide Excision Repair |
0.0 | 0.7 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 2.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.5 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.6 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.8 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.5 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 1.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.0 | 0.9 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.3 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.0 | 2.0 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 1.1 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.9 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 1.2 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.1 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.0 | 0.8 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 1.0 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.5 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.6 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 1.3 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 2.4 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.0 | 0.5 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.0 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 0.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.3 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 4.1 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 1.7 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 1.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.4 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 0.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.1 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 0.8 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.3 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.8 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.0 | 0.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.4 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 0.3 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.0 | 0.2 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.5 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.0 | 0.1 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.5 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.0 | 0.8 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.1 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 1.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.2 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 0.1 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.4 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.3 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 1.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.6 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |